Company profile
ViroLogik GmbH company profile
ViroLogik is a biopharmaceutical company which is focusing on innovative drugs for treatment of viral diseases. The focus is on Hepatitis C (HCV). Second indication is HIV- (Human Immunodeficiency Virus, AIDS) infections. ViroLogik is following a novel strategy to prevent formation of drug resistance. ViroLogik has clinical proof of concept with a proteasome inhibitor in Hepatitis C patients refractory to standard therapy. Formal preclinical development of ViroLogik’s own development candidate VL-01 is progressing. ViroLogik is following a novel strategy to prevent formation of drug resistance. The approach aims at inhibition of the highly conserved host cell proteasome which is essential..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Contact email
- [email protected]
- Phone number
- (364) 163-6442
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Founded
- 2006-01-01
Headquarters
- Headquarters
- Kleinniedesheim, Rheinland-Pfalz, Germany
- Postal code
- D 07749
- Country code
- DE
- Continent
- Europe